Provided by Tiger Trade Technology Pte. Ltd.

Innoviva

20.66
+0.04000.19%
Post-market: 20.660.00000.00%19:30 EDT
Volume:727.35K
Turnover:14.98M
Market Cap:1.49B
PE:4.80
High:20.88
Open:20.84
Low:20.45
Close:20.62
52wk High:25.15
52wk Low:16.52
Shares:72.25M
Float Shares:69.02M
Volume Ratio:1.00
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.30
EPS(LYR):3.30
ROE:36.68%
ROA:6.95%
PB:1.21
PE(LYR):6.26

Loading ...

Armata Pharma Amends 8-K to Disclose Director Daniel Gilmer Committee Assignment

Reuters
·
Jun 25

Armata Pharmaceuticals receives additional USD 2.5 million DoD funding for AP-SA02 program

Reuters
·
Jun 23

Innoviva Is Maintained at Buy by BTIG

Dow Jones
·
Jun 23

Innoviva Maintained at Buy as Analyst Highlights Nortiva LYNX Platform Upside, Keeps $46 Price Target Unchanged

TIPRANKS
·
Jun 22

Innoviva unit Nortiva Bio launches to develop monthly long-acting oral medicines

Reuters
·
Jun 18

Nortiva Bio Launches To Develop Long-Acting Oral Medicines

Reuters
·
Jun 18

Nortiva Bio Launches to Develop Long-Acting Oral Medicines

THOMSON REUTERS
·
Jun 18

Armata Pharmaceuticals shareholders elect seven directors at annual meeting

Reuters
·
Jun 17

Innoviva' Specialty Therapeutics Unit Signs Licensing Deal With Dr. Reddy's for Xacduro

MT Newswires Live
·
Jun 16

Innoviva announces distribution, licensing agreement with Dr. Reddy’s

TIPRANKS
·
Jun 16

Innoviva - Agreement Expands Xacduro Access for Acinetobacter Infections in Select International Markets

THOMSON REUTERS
·
Jun 16

Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement With DR. Reddy’s for Xacduro® in Select International Markets

THOMSON REUTERS
·
Jun 16

Innoviva - to Receive Upfront, Milestone Payments and Tiered Royalties Under Agreement

THOMSON REUTERS
·
Jun 16

Innoviva to present at Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
Jun 01

Innoviva Price Target Maintained With a $46.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 01

Analyst Reiterates Buy on Innoviva, Maintains $46 Price Target on Strong Earnings and Strategic Investments

TIPRANKS
·
Jun 01

Innoviva Board Shift And New Treatment Launch Create Valuation Question

Simply Wall St.
·
May 31

Innoviva Price Target Maintained With a $42.00/Share by BTIG

Dow Jones
·
May 26

Innoviva files Form 3 for director Josephine Linden initial beneficial ownership statement

Reuters
·
May 21

Innoviva Appoints Josephine Linden to Strengthen Board Oversight

TIPRANKS
·
May 19